IL-1β and IL-6 can induce EMT in breast cancer cells via the STAT3 pathway and promote angiogenesis, which suggests that BMAs may similarly exacerbate bone destruction in lung cancer bone metastasis (Figure 2). This evidence concerns the gene IL6 and lung carcinoma.